BPC-157 vs Phosphate Buffered Saline
A side-by-side research comparison of BPC-157 and Phosphate Buffered Saline across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | BPC-157 | Phosphate Buffered Saline |
|---|---|---|
| Full name | Body Protection Compound-157 | Phosphate Buffered Saline (PBS) |
| Category | Healing & Recovery | Healing & Recovery |
| Status | Research compound | Buffer solvent |
| Mechanism | Upregulates growth factor expression including VEGF and promotes angiogenesis, modulates nitric oxide system, and interacts with the dopaminergic system. | The phosphate buffer maintains a stable, near-physiological pH (~7.4) while the saline provides isotonic conditions, protecting peptides and proteins from pH-driven degradation during dissolution and handling. |
| Molecular weight | 1419.53 Da | Buffered salt solution |
| Half-life | ~4 hours | N/A (solvent) |
| Bioavailability | Variable; oral and injectable forms available | N/A (diluent) |
| Typical dose | 250-500 mcg per dose | Volume to reach target concentration |
| Frequency | 1-2x daily | As needed to reconstitute |
| Route | Subcutaneous injection (or oral capsules) | Added to peptide/protein vial |
BPC-157 reported benefits
- Accelerated tendon and ligament healing
- Gut lining protection and repair
- Neuroprotective effects
- Anti-inflammatory properties
- Muscle tear recovery
Phosphate Buffered Saline reported benefits
- Maintains stable physiological pH
- Isotonic and gentle on peptides/proteins
- Neutral research-grade diluent
Related comparisons
Research and educational reference only. Not medical advice.